Flavonoids for reduction of atherosclerotic risk

Current Atherosclerosis Reports

Volumn 6, Issue 1, 2004, Pages 73-78

  Maron, David J ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CATECHIN; DAIDZEIN; EPICATECHIN; EPIGALLOCATECHIN; FLAVONOID; GALLOCATECHIN; GENISTEIN; HESPERIDIN; HYDROGEN PEROXIDE; KAEMPFEROL; LOW DENSITY LIPOPROTEIN; LUTEOLIN; MALVIDIN CHLORIDE; MYRICETIN; NARINGENIN; POLYPHENOL DERIVATIVE; PROCYANIDIN; QUERCETIN; THEAFLAVIN;

ADULT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APPLE; BERRY; BEVERAGE; BROCCOLI; CACAO; CARDIOVASCULAR RISK; CELERY; CEREBROVASCULAR DISEASE; CHERRY; CITRUS FRUIT; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; FIBRINOLYSIS; FOOD INTAKE; GRAPE; HEART PROTECTION; HUMAN; LEGUME; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OXIDATION; PARSLEY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RED WINE; REVIEW; SOYBEAN; TEA; THROMBOSIS PREVENTION; TOMATO;

EID: 3042625385     PISSN: 15233804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11883-004-0119-1     Document Type: Review

References (53)

1. Hu FB, Willett WC: Optimal diets for prevention of coronary heart disease. JAMA 2002, 288:2569-2578.
2. Steinberg FM, Bearden MM, Keen CL: Cocoa and chocolate flavonoids: implications for cardiovascular health. J Am Diet Assoc 2003, 103:215-223.
3. Ross JA, Kasum CM: Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002, 22:19-34.
4. Rice-Evans CA, Miller NJ, Paganga G: Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996, 20:933-956.
5. Hertog MG, Feskens EJ, Hollman PC, et al.: Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
6. Hertog MG, Kromhout D, Aravanis C, et al.: Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995, 155:381-386.
7. Keli SO, Hertog MG, Feskens EJ, Kromhout D: Dietary flavonoids, antioxidant vitamins, and the incidence of stroke: the Zutphen Study. Arch Intern Med 1996, 156:637-642.
8. Knekt P, Jarvinen F, Reunanen A, Maatela J: Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 1996, 312:478-481.
9. Hertog MG, Feskens EJ, Kromhout D: Antioxidant flavonols and coronary heart disease risk [letter]. Lancet 1997, 349:699.
10. Yochum L, Kushi LH, Meyer K, Folsom AR: Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. Am J Epidemiol 1999, 149:943-949.
11. Hirvonen T, Pietinen P, Virtanen et al.: intake of flavonols and flavones and risk of coronary heart disease in mate smokers. Epidemiology 2001, 12:62-67.
12. Knekt P, Kumpulainen J, Järvinen R, et al.: Flavonoid intake and risk of chronic disease. Am J Clin Nutr 2002, 76:560-568.
13. Geleijnse JM, Launer LJ, van der Kuip DA, et al.: Inverse association of tea and flavonoid intakes with incident myocardial infarction: the Rotterdam Study. Am J Clin Nutr 2002, 75:880-886.
14. Hertog MG, Sweetnam PM, Fehily AM, et al.: Antioxidant flavonols and ischemic heart disease in a Welsh population of men: the Caerphilly Study. Am J Clin Nutr 1997, 65:1489-1494.
15. Rimm EB, Katan MB, Ascherio A, et al.: Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996, 125:384-389.
16. Hirvonen T, Virtamo J, Korhonen P, et al.: Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000, 31:2301-2306.
17. Sesso HD, Gaziano JM, Liu S, Buring JE: Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003, 77:1400-1408.
18. Kris-Etherton PM, Keen CL: Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 2002, 13:41-49.
19. Arts IC, Hollman PC, Kromhout D: Chocolate as a source of tea flavonoids. Lancet 1999, 354:488.
20. Osakabe N, Baba S, Yasuda A, et al.: Daily cocoa intake reduces the susceptibility of low-density lipoprotein to oxidation as demonstrated in healthy human olunteers. Free Radic Biol Res 2001, 34:93-99.
21. Wan Y, Vinson JA, Etherton TD, et al.: Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentration in humans. Am J Clin Nutr 2001, 74:596-602.
22. Rein D, Paglieroni TG, Pearson DA, et al.: Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 2000, 130:2120S-2126S.
23. Schramm DD, Wang JF, Holt RR, et al.: Chocolate procyanidins decrease the leukotriene-prostacyclin ratio in humans and human aortic endothelial cells. Am J Clin Nutr 2001, 73:36-40.
24. Karim M, McCormick K, Kappagoda CT: Effects of cocoa extracts on endothelium-dependent relaxation. J Nutr 2000, 130:2105S-2108S.
25. Goldberg IJ, Mosca L, Piano MR, Fisher EA: Wine and your heart: a science advisory for healthcare professionals, from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing for the American Heart Association. Circulation 2001, 103:472-475.
26. Renaud S, de Lorgeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
27. Aviram M, Fuhrman B: Wine flavonoids protect against LDL oxidation and atherosclerosis. Ann NY Acad Sci 2002, 957:146-161.
28. Frankel EN, Kanner J, German JB, et al.: Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341:454-457.
29. Pal S, Ho N, Santos C, et al.: Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of apoprotein B 100 from human HepG2 cells. J Nutr 2003, 133:700-706.
30. Hashimoto M, Kim S, Eto M, et al.: Effect of acute intake of red wine on flow-mediated vasodilation of the brachial artery. Am J Cardiol 2001, 88:1457-1460.
31. Stein JH, Keevil JG, Wiebe DA, et al.: Purple grape juice improves endothelial function and reduces susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 1999, 100:1050-1055.
32. Corder R, Douthwaite JA, Lees DM, et al.: Endothelin-1 synthesis reduced by red wine. Nature 2001, 414:863-864.
33. Diebolt M, Bucher B, Andriantsitohaina R: Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 2001, 38:159-165.
34. Wallerath T, Poleo D, Li H, Förstermann U: Red wine increases the expression of human endothelial nitric oxide synthase: a mechanism that may contribute to its beneficial cardiovascular effects. J Am Coll Cardiol 2003, 41:471-478.
35. Iijima K, Yoshizumi M, Hashimoto M, et al.: Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and down regulate expression of cyclin A gene. Circulation 2000, 101:805-811.
36. Pignatelli P, Pulcinelli FM, Celestini A, et al.: The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000, 72:1150-1155.
37. Shanmuganayagam D, Beahm MR, Osman HE, et al.: Grape seed and grape skin extracts elicit a greater antiplatelet effect when used in combination than when used individually in dogs and humans. J Nutr 2002, 132:3592-3598.
38. Peters U, Poole C, Arab L: Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol 2001, 154:495-503.
39. Lakenbrink C, Lapezynski S, Maiwald B, Engelhardt UH: Flavonoids and other polyphenols in consumer brews of tea and other caffeinated beverages. J Agric Food Chem 2000, 48:2848-2852.
40. Ishikawa T, Suzukawa M, Ito T, et al.: Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997, 66:261-266.
41. Duffy SJ, Keaney JF, Holbrook M, et al.: Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104:151-156.
42. Duffy SJ, Vita JA, Holbrook M, et al.: Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 2001, 21:1084-1089.
43. Loktionov A, Bingham SA, Vorster H, et al.: Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br J Nutr 1998, 79:133-139.
44. Middleton E, Kandaswami C, Theoharides TC: The Effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000, 52:673-751.
45. Riemersma RA, Rice-Evans CA, Tyrrell RM, et al.: Tea flavonoids and cardiovascular health. Q J Med 2001, 94:277-282.
46. Princen HM, van Duyvenvoorde W, Buytenhek R, et al.: No effect of consumption of green and black tea on plasma lipid an antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998, 18:833-841.
47. Maron DJ, Lu GP, Cai NS, et al.: Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003, 163:1448- 453.
48. Ikeda I, Imasato Y, Sasaki E, et al.: Tea catechins decrease micellar solubility and intestinal absorption of cholesterol in rats. Biochim Biophys Acta 1992, 1127:141-146.
49. Yang TT, Koo MW: Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sci 2000, 66:411-423.
50. Sayama K, Lin S, Zheng G, Oguni I: Effects of green tea on growth, food utilization and lipid metabolism in mice. In Vivo 2000, 14:481-484.
51. Bursill C, Roach PD, Bottema CD, Pal S: Green tea upregulates the low-density lipoprotein receptor through the sterol-regulated element binding protein in HepG2 liver cells. J Agric Food Chem 2001, 49:5639-5645.
52. Young W, Hotovec RL, Romero AC: Tea and atherosclerosis. Nature 1967, 216:1015-1016.
53. Miura Y, Chiba T, Tomita I, et al.: Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 2001, 131:27-32.